• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(二磷酸腺苷 - 核糖)聚合酶 -1 在皮肤恶性黑色素瘤中的表达作为侵袭性肿瘤的一种新分子标志物。

Poly(adenosine diphosphate-ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor.

作者信息

Csete Béla, Lengyel Zsuzsanna, Kádár Zsolt, Battyáni Zita

机构信息

Department of Dermatology, University of Pécs, 20. Kodály Z. u., Pécs, Hungary.

出版信息

Pathol Oncol Res. 2009 Mar;15(1):47-53. doi: 10.1007/s12253-008-9086-0. Epub 2008 Aug 28.

DOI:10.1007/s12253-008-9086-0
PMID:18752052
Abstract

Poly(adenosine diphosphate-ribose) polymerases (PARPs) are a family of enzymes, which catalyses poly (ADP-ribosyl)ation of DNA-binding proteins and directly involved in genomic stability, DNA repair, and apoptosis. In this study, we evaluated the immunomorphology of PARP-1 in melanoma and its prognostic importance. We studied PARP-1 expression by immunohistochemistry in a selected series of 54 primary cutaneous malignant melanoma (CMM). The findings of the present study suggest that the neoplastic progression toward the invasive (both horizontal and vertical) growth phase of CMM cells is characterized by the loss of cleavage of PARP-1, probably signaling an imbalance of the apoptotic process in these cells and leading to further gain to aggression. Over-expression of full-length PARP-1 was correlated with recurrence and/or progression of the disease and so act as a promising new biological marker of CMM. Our study represents the evidence of a direct correlation between the PARP-1-mediated apoptotic process and the biologic behavior of CMM.

摘要

聚(腺苷二磷酸核糖)聚合酶(PARP)是一类酶,可催化DNA结合蛋白的聚(ADP-核糖基)化,并直接参与基因组稳定性、DNA修复和细胞凋亡。在本研究中,我们评估了PARP-1在黑色素瘤中的免疫形态学及其预后意义。我们通过免疫组织化学研究了54例原发性皮肤恶性黑色素瘤(CMM)的选定系列中PARP-1的表达。本研究结果表明,CMM细胞向侵袭性(水平和垂直)生长阶段的肿瘤进展的特征是PARP-1裂解的丧失,这可能表明这些细胞中凋亡过程的失衡,并导致进一步的侵袭性增加。全长PARP-1的过度表达与疾病的复发和/或进展相关,因此可作为CMM有前景的新生物标志物。我们的研究代表了PARP-1介导的凋亡过程与CMM生物学行为之间直接相关性的证据。

相似文献

1
Poly(adenosine diphosphate-ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor.聚(二磷酸腺苷 - 核糖)聚合酶 -1 在皮肤恶性黑色素瘤中的表达作为侵袭性肿瘤的一种新分子标志物。
Pathol Oncol Res. 2009 Mar;15(1):47-53. doi: 10.1007/s12253-008-9086-0. Epub 2008 Aug 28.
2
Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.头颈部光暴露区域恶性黑色素瘤中聚(腺苷二磷酸核糖)聚合酶1的表达
Hum Pathol. 2005 Jul;36(7):724-31. doi: 10.1016/j.humpath.2005.04.017.
3
Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.多聚(ADP-核糖)依赖性调控 Snail1 蛋白稳定性。
Oncogene. 2011 Oct 20;30(42):4365-72. doi: 10.1038/onc.2011.153. Epub 2011 May 16.
4
PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma.PARP1 表达预测 PARP 抑制剂敏感性,并与黑色素瘤的转移潜能和总生存相关。
Int J Cancer. 2024 Jul 15;155(2):203-210. doi: 10.1002/ijc.34947. Epub 2024 Apr 15.
5
Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellular tumour spheroid model.多聚(ADP-核糖)聚合酶在胶质母细胞瘤及胶质瘤多细胞肿瘤球体模型中的表达与多聚(ADP-核糖基)化分布
Neuropathol Appl Neurobiol. 2000 Dec;26(6):528-35. doi: 10.1046/j.0305-1846.2000.00288.x.
6
Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis.核蛋白的瞬时多聚(ADP - 核糖)化及多聚(ADP - 核糖)聚合酶在细胞凋亡早期阶段的作用。
J Biol Chem. 1998 May 29;273(22):13703-12. doi: 10.1074/jbc.273.22.13703.
7
Poly(ADP-ribosyl)ation in carcinogenesis.聚(ADP-核糖)化在致癌作用中的研究进展。
Mol Aspects Med. 2013 Dec;34(6):1202-16. doi: 10.1016/j.mam.2013.05.003. Epub 2013 May 25.
8
Interaction of PARP-2 with DNA structures mimicking DNA repair intermediates and consequences on activity of base excision repair proteins.PARP-2 与模拟 DNA 修复中间体的 DNA 结构相互作用及其对碱基切除修复蛋白活性的影响。
Biochimie. 2013 Jun;95(6):1208-15. doi: 10.1016/j.biochi.2013.01.007. Epub 2013 Jan 26.
9
Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.硫芥气和氮芥气在HaCaT角质形成细胞中诱导出具有独特细胞后果的特征性多(ADP-核糖基)化反应。
Toxicol Lett. 2016 Feb 26;244:56-71. doi: 10.1016/j.toxlet.2015.09.010. Epub 2015 Sep 14.
10
Poly(ADP-ribosyl)ation, PARP, and aging.聚(ADP-核糖)化、PARP与衰老
Sci Aging Knowledge Environ. 2004 Dec 8;2004(49):re9. doi: 10.1126/sageke.2004.49.re9.

引用本文的文献

1
Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.人 DAB2IP 基因表达下调导致肾细胞癌对电离辐射产生抗性。
Clin Cancer Res. 2019 Jul 15;25(14):4542-4551. doi: 10.1158/1078-0432.CCR-18-3004. Epub 2019 Apr 18.
2
Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.基于晶体结构发现一种新型合成的PARP1抑制剂(OL-1)及其在三阴性乳腺癌中的凋亡诱导机制
Sci Rep. 2016 Dec 5;6(1):3. doi: 10.1038/s41598-016-0007-2.
3
PARP1 Inhibitors: antitumor drug design.

本文引用的文献

1
Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.头颈部光暴露区域恶性黑色素瘤中聚(腺苷二磷酸核糖)聚合酶1的表达
Hum Pathol. 2005 Jul;36(7):724-31. doi: 10.1016/j.humpath.2005.04.017.
2
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.聚(ADP-核糖基)化与癌症和自身免疫性疾病的关系。
Cell Mol Life Sci. 2005 Apr;62(7-8):769-83. doi: 10.1007/s00018-004-4509-x.
3
Mechanism of early biphasic activation of poly(ADP-ribose) polymerase-1 in response to ultraviolet B radiation.
聚(ADP-核糖)聚合酶1(PARP1)抑制剂:抗肿瘤药物设计
Acta Naturae. 2015 Jul-Sep;7(3):27-37.
4
Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.抑制聚(ADP-核糖)聚合酶1通过抑制骨髓增殖性白血病病毒癌基因来预防急性髓系白血病。
Oncotarget. 2015 Sep 29;6(29):27490-504. doi: 10.18632/oncotarget.4748.
5
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.NQO1基因多态性及p53、SOD2、PARP1在局限期小细胞肺癌中的表达的临床意义
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6743-51. eCollection 2014.
6
Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue.多聚(ADP-核糖)聚合酶 1 蛋白在正常和肿瘤前列腺组织中的表达。
Eur J Histochem. 2013 Apr 15;57(2):e13. doi: 10.4081/ejh.2013.e13.
7
Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).BAG-1 和 PARP-1 在人乳头瘤病毒(HPV)相关的宫颈前病变和浸润性宫颈癌中的表达。
Pathol Oncol Res. 2012 Oct;18(4):929-37. doi: 10.1007/s12253-012-9523-y. Epub 2012 Mar 28.
8
PARP-1 and PARP-2: New players in tumour development.聚(ADP-核糖)聚合酶-1和聚(ADP-核糖)聚合酶-2:肿瘤发展中的新角色。
Am J Cancer Res. 2011;1(3):328-346. Epub 2011 Jan 8.
9
Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target.小儿高级别胶质瘤:聚(ADP-核糖)聚合酶作为潜在治疗靶点的鉴定。
Neuro Oncol. 2011 Nov;13(11):1171-7. doi: 10.1093/neuonc/nor115. Epub 2011 Aug 17.
聚(ADP-核糖)聚合酶-1响应紫外线B辐射的早期双相激活机制。
J Cell Sci. 2005 Feb 1;118(Pt 3):589-99. doi: 10.1242/jcs.01636. Epub 2005 Jan 18.
4
The PARP superfamily.聚(ADP - 核糖)聚合酶超家族
Bioessays. 2004 Aug;26(8):882-93. doi: 10.1002/bies.20085.
5
Tumor necrosis factor-alpha induces apoptosis associated with poly(ADP-ribose) polymerase cleavage in HT-29 colon cancer cells.肿瘤坏死因子-α诱导HT-29结肠癌细胞中与聚(ADP-核糖)聚合酶裂解相关的细胞凋亡。
Anticancer Res. 2002 May-Jun;22(3):1635-9.
6
Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism.洛伐他汀通过凋亡依赖性机制增强阿霉素对小鼠黑色素瘤的抗肿瘤活性。
Int J Cancer. 2002 Jul 1;100(1):111-8. doi: 10.1002/ijc.10440.
7
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin.接受基于细胞因子治疗的晚期黑色素瘤患者的生存预后因素及与长期缓解相关的因素:欧洲癌症研究与治疗组织(EORTC)黑色素瘤协作组一项随机试验的二次分析,该试验比较了α-干扰素2a(IFNα)和白细胞介素2(IL-2)联合或不联合顺铂的疗效。
Eur J Cancer. 2002 Jul;38(11):1501-11. doi: 10.1016/s0959-8049(02)00123-5.
8
Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.人黑色素瘤细胞对依托泊苷和顺铂的耐药性与药物依赖性凋亡缺陷有关。
J Invest Dermatol. 2002 Jun;118(6):923-32. doi: 10.1046/j.1523-1747.2002.01786.x.
9
Effects of the isoflavone 4',5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage.异黄酮4',5,7-三羟基异黄酮(染料木黄酮)对补骨脂素加紫外线A辐射(PUVA)诱导的光损伤的影响。
Carcinogenesis. 2002 Feb;23(2):317-21. doi: 10.1093/carcin/23.2.317.
10
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.美国癌症联合委员会皮肤黑色素瘤分期系统的最终版本。
J Clin Oncol. 2001 Aug 15;19(16):3635-48. doi: 10.1200/JCO.2001.19.16.3635.